FDA Clearance Tracker · P100029-S021
TRIFECTA VALVE WITH GLIDE TECHNOLOGY
Last checked: Nov 20, 2026Latest source record: Apr 24, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Apr 24, 2016
Approved
Time to decision
205 days
Received Oct 2, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100029-S021
- Device name
- TRIFECTA VALVE WITH GLIDE TECHNOLOGY
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Oct 2, 2015
- Decided
- Apr 24, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P100029
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the addition of the Trifecta Valve with Glide Technology (Trifecta GT).
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.